10 Small-Cap Stocks With Huge Growth Potential
On February 19, Ben Snider, Goldman Sachs chief U.S. equity strategist, appeared on CNBC’s ‘Money Movers’ to talk about his playbook for equities, among other things.
Biocryst Pharmaceuticals Inc (BCRX)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 15,827,186 | $123,452,051 | 1.26% | |
| 2. | Deerfield Management James E. Flynn | 14,341,000 | $111,859,800 | +18% | 1.43% |
| 3. | Kynam Capital Derrick Tang | 9,366,526 | $73,058,903 | -1% | 4.67% |
| 4. | Two Sigma Advisors John Overdeck And David Siegel | 4,089,112 | $31,895,074 | -4% | 0.06% |
| 5. | Perceptive Advisors Joseph Edelman | 3,162,529 | $24,667,726 | 0.44% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $6.36 | 7,861 | $49,995.96 | 44,951 | 2024-05-30 | Filing | |
| $6.40 | 2,500 | $16,000.00 | 2,500 | 2024-05-24 | Filing | |
| $6.38 | 5,000 | $31,900.00 | 86,818 | 2024-05-20 | Filing | |
| $6.25 | 15,000 | $93,750.00 | 66,997 | 2024-05-20 | Filing | |
| $5.57 | 36,300 | $202,191.00 | 266,744 | 2024-05-14 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $7.65 | 21,773 | $166,563.45 | 398,751 | 2025-12-22 | Filing | |
| $7.65 | 21,210 | $162,256.50 | 315,726 | 2025-12-15 | Filing | |
| $7.65 | 19,770 | $151,240.50 | 345,476 | 2025-12-03 | Filing | |
| $7.21 | 50,906 | $367,215.52 | 365,246 | 2025-12-02 | Filing | |
| $7.10 | 91,004 | $646,510.62 | 416,152 | 2025-12-01 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 22,273,375 | $173,732,325 | 0% | |
| 2. | 21,137,791 | $164,874,767 | 0% | |
| 3. | 11,073,211 | $86,371,046 | 0% | |
| 4. | 7,404,386 | $57,791,233 | 0.03% | |
| 5. | 5,263,914 | $41,058,529 | 0.01% |
News See All
Evercore ISI Sees Long-Term Growth Potential For BioCryst Pharmaceuticals, Inc. (BCRX) Following Astria Acquisition
TheFly reported on February 18 that Evercore ISI reinstated coverage of BCRX with an Outperform rating and a $17 price target.
7 Oversold Pharma Stocks to Buy Now
In 2024, the pharmaceutical sector in the United States was valued at $634.32 billion, and by 2030, it is expected to have grown to $883.97 billion.
Jim Cramer Commented on These 14 Stocks
There is a reason I always hesitate to recommend the hottest stocks in the market, the ones with the parabolic moves, the monstrous one-day gains.
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best small cap stocks to buy with huge upside potential. H.C. Wainwright lifted the price target on BioCryst Pharmaceuticals Inc.
12 Small Cap Stocks to Buy with Huge Upside Potential
Talking about rotation in the market, she expects the trend to continue for a while, with the capital basically moving from the high multiple mega cap winners towards small caps, cyclicals, and the international...
BioCryst Data Highlights Severe Psychosocial Burden of HAE on Pediatric Patients, Caregivers
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best upside stocks to buy now.
12 Best Upside Stocks to Buy Now
On November 14, Alli McCartney, UBS Private Wealth Management managing director, joined 'Squawk Box' on CNBC to discuss the latest market trends and what to make of the recent volatility.
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript
BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) Q3 2025 Earnings Call Transcript November 3, 2025BioCryst Pharmaceuticals, Inc. misses on earnings expectations.
BioCryst Sells European ORLADEYO Business for $250M Upfront to Focus on US Market
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best stocks to buy under $20.
Hedge Fund Resource Center